Spectree LLC, 4508 Bagley Ave N, Seattle, WA 98103, US

Sound Pharmaceuticals, Inc. (SPI) is a privately held biopharmaceutical company based in Seattle, WA. They are dedicated to developing novel therapeutics that aim to prevent and treat various forms of hearing loss, including sensorineural hearing loss and tinnitus. With an estimated 50 million Americans affected by these conditions, SPI's groundbreaking research and development efforts have the potential to significantly impact the lives of millions. Driven by the mission to address the lack of FDA-approved drugs for inner ear disorders, SPI is at the forefront of pioneering treatments for hearing loss and tinnitus. Their innovative approach and commitment to advancing the field of neurotology have positioned them as a leading player in the industry, with a focus on developing therapeutics that can make a tangible difference in the lives of individuals suffering from these prevalent conditions.Generated from the website